BIOTESS CAPRAMAX
LIVE

Serial Number

99391333

Owner

Tesseract Medical Research, LLC

First Use Date

Feb 1, 2026

Filing Date

Sep 13, 2025

Add to watchlist:

No watchlists yet
View on USPTO

BIOTESS CAPRAMAX Trademark

Serial Number: 99391333

BIOTESS CAPRAMAX is a trademark filed by Tesseract Medical Research, LLC on September 13, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Tesseract Medical Research, LLC (58 trademarks)

1370 Trancas Street, Suite 350
Napa, CA 94558

Entity Type: 16

Trademark Details

Filing Date

September 13, 2025

Registration Date

Not Registered

First Use Anywhere

February 1, 2026

First Use in Commerce

February 1, 2026

Published for Opposition

January 27, 2026

Goods & Services

Pharmaceutical feature in the nature of proprietary nutrient-delivery agents that enhance nutrient absorption and bioavailability, namely, a feature in the nature of nutrient delivery agents in the form of powders that provide controlled release of active ingredients for a wide variety of dietary supplements, nutritional supplements, and pharmaceutical preparations, sold as an integral component of dietary supplements, nutritional supplements, and pharmaceutical preparations for the treatment of cardiovascular, neurological, cognitive, digestive, inflammatory, anxiety, weight management, and metabolic health conditions.

Filing History

STATEMENT OF USE PROCESSING COMPLETE
Jun 23, 2026 SUPC
USE AMENDMENT FILED
Mar 25, 2026 IUAF
TEAS STATEMENT OF USE RECEIVED
Mar 25, 2026 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 24, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 27, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jan 27, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 21, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 5, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 31, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 31, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 31, 2025 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 29, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 29, 2025 GNSL
SUSPENSION LETTER WRITTEN
Dec 29, 2025 CNSL
ASSIGNED TO EXAMINER
Dec 17, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 13, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 13, 2025 NWOS
NEW APPLICATION ENTERED
Sep 13, 2025 NWAP